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Abstract
Background and purpose: The Six-Minute Walk Test (6MWT) has been employed as a measure
of functional capacity, but its relationship to cardiorespiratory fitness in stroke is not well
established. Gait speed measured over short distances is commonly used as an index of walking
competency following stroke. We evaluated the relationship between the 6MWT, aerobic fitness
(VO2peak) and walking competency in sub-acute stroke.
Methods: Thirty-six individuals (mean age ± SD, 64.6 ± 14.4 years; time post-stroke 16.2 ± 13.3
days) were evaluated using the 6MWT (distance, speed, heart rate), a maximal exercise test
(VO2peak, heart rate, exercise test duration), and walking competency using a five meter walk
(speed, symmetry ratio). Correlation analyses were used to examine the relationships between
these outcomes.
Results: There was a strong correlation between the 6MWT and five meter walk velocity for
preferred (r = 0.79) and fast (r = 0.82) speed (p < 0.001). On average, the 6MWT speed was faster
than the preferred gait speed (94.9 cm/s vs. 83.8 cm/s, p = 0.003), but slower than the fast-paced
walk (115.1 cm/s, p < 0.001). There was significant though more moderate association between
6MWT distance and VO2peak (r = 0.56, p < 0.001) and exercise test duration (r = 0.60, p < 0.001).
Conclusion: The speed selected during the 6MWT was strongly related to the velocities selected
during the five meter walk distance (intermediate to the selected preferred and fast speeds).
Although the 6MWT may be challenging to the cardiorespiratory system, it appears to be more
strongly influenced by potential limits to walking speed rather than cardiorespiratory capacity. As
a result, this test is not, by itself, an adequate measure of aerobic fitness early after stroke.
Background
Stroke is the leading cause of adult disability in North
America [1,2]. Functional ambulation is often compro-
mised [3-6], and reduced independence in walking is a
commonly reported concern among stroke survivors [7].
This is further complicated by reductions in cardiorespira-
tory fitness after stroke [4,8-10], changes in neuromotor
control [5] and increased energy demands associated with
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performing everyday activities [6,10]. These issues under-
score the need for valid testing procedures to evaluate aer-
obic fitness and walking ability following stroke.
The measurement of maximal oxygen consumption dur-
ing graded exercise testing is the gold standard for evalu-
ating cardiorespiratory fitness [11]. However, stroke-
related impairments such as changes in strength and sen-
sory function may limit the use of graded maximal exer-
cise tests with this population. Exercise testing is also
expensive and time- and resource-intensive, and testing
equipment is not readily available in most clinical set-
tings. As an alternative, walk tests were designed as an
objective measure of functional status and have been
employed as a surrogate measure of cardiorespiratory fit-
ness among several populations. In individuals with car-
diorespiratory conditions for whom these tests were
originally designed, correlations between Six-Minute
Walk Test (6MWT) distance and VO2max range from 0.51
to 0.90 [12]. As there are multiple factors that may con-
tribute to walk test performance among stroke survivors,
the relationship between the 6MWT and aerobic capacity
is not well established among stroke survivors, with asso-
ciations ranging from none [9] to low (0.40, p < 0.005)
[3] in chronic stroke and high correlation (0.84, p <
0.001) [4] in sub-acute stroke. In light of this variability,
there is a need to better understand the determinants of
the 6MWT that may influence its potential utility as a sub-
maximal measure of cardiorespiratory fitness after stroke.
The relationship between the 6MWT and aerobic fitness in
the stroke population may be confounded by limitations
in walking competency arising from neuromotor control
challenges. Another commonly used index of walking
ability is gait speed measured over short distances (5–10
meters), which is considered primarily dependent on neu-
romotor control rather than aerobic fitness. Preferred
(self-selected) and maximum gait speed is easily meas-
ured in the clinical setting, and preferred gait speed is
commonly used as an outcome measure of walking com-
petency in stroke rehabilitation, having been shown to be
able to detect minimally clinically relevant change
(responsive) in the sub-acute stroke population [13].
The purpose of this study was to examine the relation-
ships between 6MWT, aerobic fitness (VO2peak) and
walking competency (five meter walk) in sub-acute stroke
(medically stable and < 3 months post). This work has
important clinical implications for the evaluation of walk-
ing ability and cardiorespiratory fitness early post-stroke.
As exercise training becomes increasingly recognized as an
integral component of stroke rehabilitation programs
during this important stage of recovery, valid and efficient
tools for specifically evaluating aerobic and functional
outcomes of interest are needed.
Methods
The study procedures were followed in accordance to
institutional guidelines and were approved by the local
university and hospital research ethics committees.
Informed written consent was obtained from all study
participants. This study was part of a larger trial examining
the effect of exercise in the sub-acute stroke population.
Participants
Thirty-six patients with stroke were recruited from a reha-
bilitation facility and were included if they were able to
provide informed consent, understand the evaluation
procedures, walk at least five meters independently, have
a Chedoke-McMaster Stroke Assessment (CMSA) [14] leg
impairment score greater than 2 (where active voluntary
movement is present without facilitation), and were less
than three months post-stroke upon entry into the study.
Participants were excluded if they exhibited any contrain-
dications to maximal exercise testing as outlined by the
American College of Sports Medicine (ACSM) [15], or
musculoskeletal impairments or pain which would limit
the ability to perform the tests.
Participant characteristics noted included demographic
information, lesion type and location, time post-stroke,
degree of neurologic deficit (motor, sensory, aphasia,
apraxia, neglect) using the National Institutes of Health
Stroke Scale [16], functional ability using the Functional
Independence Measure [17], and level of leg impairment
using the CMSA, where a score of 1 indicates flaccid paral-
ysis, 3 describes a limb where spasticity and weakness are
marked and 7, the maximum score, indicates normal limb
function including complex movement patterns with
appropriate muscle timing and coordination [14].
Measures
All measures detailed below were performed during inpa-
tient rehabilitation, with all but two participants closer to
discharge. Typical duration of rehabilitation is 4–5 weeks,
and includes physical, occupational, speech and language
therapy 2–5 days per week.
A) Six-minute walk test (6MWT)
Standardized instructions [18] were given to walk as far as
possible over a 30-meter course in six minutes. Heart rate
(HR) and rating of perceived exertion (modified 0–10
Borg scale) [19] were noted at the start and end of the test,
as well as the use of walking aids. No encouragement was
provided during the test. The distance covered in six min-
utes was the primary outcome of this test. Because of the
known practice effect with the 6MWT in the cardiorespira-
tory population, participants were familiarized with the
test with at least one practice trial before the actual meas-
urement was taken. Gait speed, in cm/s, was determined
[(distance covered during the 6MWT (m)/360 s) × 100].Journal of NeuroEngineering and Rehabilitation 2006, 3:23 http://www.jneuroengrehab.com/content/3/1/23
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B) Cardiorespiratory fitness
A semi-recumbent cycle ergometer (Biodex Medical Sys-
tems, Shirley, NY) was used during the maximal exercise
test and was selected to avoid the limitations in achieving
aerobic capacity in sub-acute stroke using a walking or
treadmill program. The ramp protocol included a two-
minute warm up at 10 watts with a target cadence of 50
revolutions per minute, followed by progressive 5-watt
increases in power output every minute. This protocol was
designed specifically for this study, considering issues
with strength and fatigability post-stroke and anticipating
a total test time of 8–10 minutes. Participants were famil-
iarized with the testing protocol with at least one practice
trial prior to the actual test. A metabolic cart (AEI Technol-
ogies, Pittsburgh, PA) measured respiratory gas exchange
with calculated averages at 30-second intervals. Blood
pressure was monitored using an automated system (Sun-
Tech Medical, Morrisville, NC), as was heart rate with a
heart rate monitor (Polar Electro Inc, Woodbury, NY). A
5-lead electrocardiogram (Remco Italia, Milano, Italy)
was monitored for abnormalities. The foot on the partici-
pants' hemiparetic side was secured to the pedal if neces-
sary. The test was terminated according to ACSM
guidelines [15], or if the participant was unable to main-
tain the required pedaling rate despite encouragement.
Peak oxygen uptake (VO2peak) and peak heart rate were
determined as the highest values reached from the calcu-
lated 30-second averages from the exercise test.
C) Walking competency (Five meter walk)
Spatiotemporal aspects of walking were measured using a
pressure-sensitive mat, five meters in length (CIR Systems,
Clifton, NJ). Thirty-four out of 36 participants were eval-
uated for walking competency due to initial problems in
equipment availability. Three sets of walking trials were
performed at preferred pace. A subset of 30 participants
also performed three trials walking at their maximally
comfortable speed (fast pace). The use of walking aids was
noted. A research assistant provided safety supervision
during each trial. The primary outcome measure was gait
speed (cm/s), which was averaged across the three trials at
each speed.
Gait symmetry ratio based on the preferred walk was com-
puted [(paretic leg swing time/stance time)/(non-paretic
leg swing time/stance time)]. A symmetry ratio between
0.9 and 1.1 (the 95% confidence interval for symmetry of
gait in healthy adults) indicated a symmetrical gait pattern
[20].
Data analysis
Descriptive statistics were performed on all measures.
Paired t-tests were used to determine significant differ-
ences between 6MWT speed and five meter walk gait
speed (preferred and fast). Correlation analyses were per-
formed to determine the relationships between 6MWT
distance and VO2peak, 6MWT speed and five meter walk
speeds (preferred and fast), and 6MWT distance and gait
symmetry ratio. An unpaired t-test was performed to
determine the difference between 6MWT distances
between participants with respect to gait symmetry; one-
way analysis of variance determined differences in 6MWT
between levels of leg impairment. To determine predictors
for 6MWT distance, stepwise multiple regression analysis
was performed. Statistical significance was set at p < 0.05.
Results
Participant characteristics are presented in Table 1. Partic-
ipants were admitted to rehabilitation 16.2 ± 13.3 days
post stroke, and were tested 50.3 ± 17.0 days post-stroke.
Nineteen participants did not require any gait aids for
walking, nine used a single point cane and eight used a
two-wheeled walker or rollator. Results from the 6MWT,
maximal exercise test and five meter walk are presented in
Table 2. Due to issues with testing equipment for three
individuals, gas analysis was not available for the maxi-
mal exercise test and as such, VO2peak was not measured.
However, peak HR data was available for all 36 partici-
pants.
Relationship between 6MWT and cardiorespiratory fitness 
(VO2peak)
Correlation analyses revealed 'moderate' associations
between 6MWT distance with VO2peak (r = 0.56, p <
0.001) and between heart rate achieved at the end of
6MWT and the peak heart rate during the maximal exer-
cise test (r = 0.66, p < 0.001) (Figure 1). Duration of the
maximal exercise test was also moderately correlated to
6MWT distance (r = 0.60, p < 0.001). Average heart rate
achieved at the end of the 6MWT was 85% of the peak
heart rate from the maximal exercise test (97.7 ± 19.7 ver-
sus 115.1 ± 25.9 beats per minute) (t(35) = 5.37, p <
0.001) and 60% of age-predicted maximal heart rate (162
8 ± 1.7 beats per minute) (t(35) = -22.4. p < 0.001).
Relationship between 6MWT and walking competency 
(gait speed, symmetry) and CMSA
The associations between gait speed from the 6MWT and
preferred- and fast-paced walks were stronger (r = 0.79, p
< 0.001 and r = 0.82, p < 0.001, respectively) (Figure 2).
Gait speed during the 6MWT was faster than preferred gait
speed from the five meter walk (94.9 ± 30.0 versus 83.8 ±
32.1 cm/s) (t(33) = 3.17, p = 0.003), but slower than fast-
paced five meter walk (115.1 ± 38.0 cm/s) (t(29) = 5.62,
p < 0.001).
Average symmetry ratios calculated based on the pre-
ferred- and fast-paced five meter walks are presented in
Table 2. The association between 6MWT distance and pre-
ferred walk symmetry ratio was not statistically significantJournal of NeuroEngineering and Rehabilitation 2006, 3:23 http://www.jneuroengrehab.com/content/3/1/23
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(r = -0.31, p = 0.24) and there was no significant differ-
ence in distance walked between symmetrical and asym-
metrical groups (t(32) = 1.55, p = 0.13). There were wide
ranges in 6MWT scores at all levels of CMSA leg impair-
ment scores (Stage 4: 301.1 ± 114.2 m (90–446 m), Stage
5: 291.3 ± 94.1 m (107–414 m), Stage 6: 396.4 ± 86.0 m
(250–503 m), Stage 7: 434.7 ± 59.8 m (385–501 m)).
There was no significant difference in 6MWT distance
between CMSA leg impairment scores (F (3,32) = 2.17 p =
0.11) (Figure 3).
Determinants of 6MWT distance
Variables were entered into a stepwise multiple regression
model to determine the predictors of 6MWT performance.
Variables entered into the model included: measures from
the maximal exercise test (VO2peak, peak heart rate and
exercise test duration), preferred- and fast-paced five
meter walk speeds, presence or absence of beta-blockade,
and the number of medical conditions. The five meter fast
walk (r = 0.81, p < 0.001) and exercise test duration (r =
0.87, p = 0.004) accounted for 65.4% and 9.7% of the var-
iance in 6MWT distance. None of the remaining variables,
when included in the model, led to a statistically signifi-
cant improvement in the model prediction of 6MWT var-
iance.
Discussion
The relationships between gait speed, functional walk
tests and aerobic capacity are not well established and
have only received limited attention in chronic stroke.
This study contributes to the current body of literature
that reports associations between the 6MWT and meas-
ures of cardiorespiratory fitness and walking competency
after stroke, and is the first study to make comparisons
between short-distance walk and functional walk test gait
speeds for individuals in the early post-stroke phase.
There were strong relationships between speeds during
the 6MWT and five meter walk, but the relationship
between VO2peak and the 6MWT distance was modest,
suggesting that aerobic fitness is a moderate contributor
of distance walked on the 6MWT early after stroke.
Observed results from the 6MWT are comparable to other
values in the stroke literature, slightly higher than some
(316 m, 5.5 ± 4.9 y post-stroke [3] and 302 m, 29.2 ± 11.0
d post-stroke [4]) and lower than others (378 m, 3.5 ± 2.0
y post-stroke [9]), and provide further evidence that func-
Table 2: Results from the 6MWT, maximal exercise test and five 
meter walk
nM e a n S D R a n g e
Six-Minute Walk Test
Distance (m) 36 341.6 107.9 90–503
Speed (cm/s) 36 94.9 30.0 25.0–139.7
End heart rate (bpm)† 36 97.7 18.8 63–148
Maximal exercise test
VO2peak (ml·kg-1·min-1) 33 12.3 3.1 6.6–19.2
Peak heart rate (bpm)† 36 115.0 25.9 70–175
Exercise test duration (min) 36 8.7 4.2 1.8–20.5
Gait speed (cm/s)
Preferred 34 83.8 32.1 35.2–151.3
Fast 30 115.1 38.0 47.5–179.8
Gait symmetry ratio
Preferred 34 1.11 0.24 0.63–1.73
Fast 30 1.13 0.20 0.82–1.71
† Beats per minute
Table 1: Participant characteristics
Mean SD Range
Male/Female, n 14/22
Type of stroke, n
Ischemic/Hemorrhagic/Unknown 25/10/1
Hemiparetic side, n
Right/Left/Bilateral 17/17/2
Medications
β-blockers/ACE inhibitors/None/Both 6/17/11/2
Co-morbidities
Hypertension 25
Cholesteremia 12
Diabetes mellitus 4
Coronary artery disease 8
Chronic obstructive pulmonary disease 3
History of smoking 11
Age, years 64.6 14.4 19–90
National Institutes of Health Stroke Scale* 2.8 2.3 0–10
Chedoke-McMaster Stroke Assessment Leg score 5.1 1.0 4–7
Functional Independence Measure 110.8 9.2 77–125
* Data missing for 6 participantsJournal of NeuroEngineering and Rehabilitation 2006, 3:23 http://www.jneuroengrehab.com/content/3/1/23
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tional ambulation is compromised after stroke. Gait
speed measured over short distances [4,9] is also similar
to those previous reports. With respect to the correlation
between 6MWT speed and preferred gait speed, Eng and
colleagues reported a high correlation (0.92, p < 0.01)
between self-selected gait speed and 6MWT distance for
chronic stroke survivors, and interestingly, found that
these individuals will pace themselves identically during a
6MWT and during the longer 12-Minute Walk Test [21].
Kelly et al. also reported similarly high correlations
between 6MWT distance and self-selected and maximal
gait velocities (r = 0.91 and r = 0.89, respectively) in indi-
viduals tested early after stroke [4]. Unlike the present
study, comparisons of gait speed measured over short dis-
tances and 6MWT speed were not made in either of these
previous studies. It has previously been reported that
"comfortable" ten meter gait speed is faster than average
6MWT speed, suggesting that 6MWT performance may be
dependent on aerobic capacity although somewhat inde-
pendent of locomotor control, and that walking ability
may be overestimated if gait speed is measured only over
short distances [22]. In contrast, our findings show that
Relationship between 6MWT speed and A) preferred gait speed (r = 0.79, p < 0.001), and B) fast gait speed (r = 0.82, p <  0.001) Figure 2
Relationship between 6MWT speed and A) preferred gait speed (r = 0.79, p < 0.001), and B) fast gait speed (r = 0.82, p < 
0.001). Dashed line represents line of identity. Gait speed was faster during the 6MWT compared to preferred gait speed (t = 
-3.17, p = 0.003), but slower than the fast-pace walk (t = 5.6, p < 0.001).
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Relationship between A) 6MWT distance and VO2peak (r = 0.56, p < 0.001), and B) end heart rate from 6MWT and peak 
heart rate from maximal exercise test (r = 0.66, p < 0.001), in beats per minute (bpm). Dashed line represents line of identity.
V
O
2
p
e
a
k
 
(
m
l
.
k
g
-
1
.
m
i
n
-
1
)
A.
6MWT distance (m)
0 100 200 300 400 500 600
0
5
10
15
20
25
B.
Heart rate at end of 6MWT (bpm)
0 100 200
P
e
a
k
 
h
e
a
r
t
 
r
a
t
e
 
f
r
o
m
 
m
a
x
i
m
a
l
e
x
e
r
c
i
s
e
 
t
e
s
t
 
(
b
p
m
)
0
100
200Journal of NeuroEngineering and Rehabilitation 2006, 3:23 http://www.jneuroengrehab.com/content/3/1/23
Page 6 of 8
(page number not for citation purposes)
preferred five meter gait speed is slower than 6MWT speed
and would underestimate walk test performance, despite
high correlations between the two. However, 6MWT
speed was not as fast as the fast-paced five meter walk.
Low VO2peak values, approximately 60% of age-matched
non-stroke populations [15], are comparable to findings
from other studies [4,8] and confirm that aerobic fitness
is compromised in the early stages post-stroke. The find-
ing that HR values at the end of the 6MWT were 85% of
those achieved during the maximal exercise test suggests
that the walk test is challenging to the aerobic system; fur-
ther, since 6MWT HR was only 60% of age-predicted max-
imal HR highlights the degree of de-conditioning that
occurs soon after stroke. Arguably, pre-morbid fitness may
have already been compromised prior to stroke onset due
to the presence of cardiovascular co-morbidities and med-
ication use or low activity levels, which may also account
for the altered HR response. An earlier study focusing on
sub-acute stroke reported a stronger correlation between
6MWT distance and VO2peak/age-predicted VO2max (r =
0.84, p < 0.001) [4], compared to the modest relation-
ships between 6MWT distance with VO2peak (r = 0.56, p
< 0.001) and exercise test duration (r = 0.60, p < 0.001)
found in the current study. While compromised fitness
may affect the distance walked on the 6MWT, stroke sur-
vivors likely have additional contributing impairments
that limit both walking ability and performance on a max-
imal exercise test. Likewise, modest relationships are
reported between 6MWT distance and measures of aero-
bic capacity in the cardiorespiratory domain [12]. In con-
trast, two studies investigating the relationship between
the 6MWT and VO2peak with chronic stroke survivors
found little [3] to no relationship [9], highlighting the
range in exercise and functional performance within the
stroke population. Walk tests were originally developed to
evaluate the ability of individuals with cardiorespiratory
conditions to maintain sub-maximal levels of intensity at
durations intended to represent daily activities. Stroke-
specific issues, however, such as balance and neuromotor
control issues, may limit 6MWT performance more than
cardiorespiratory fitness [3,21]. The present study contrib-
utes to the current knowledge by considering maximal
exercise test results, gait speed, medication use and health
status as potential determinants of 6MWT performance.
Stepwise multiple regression analysis revealed that the
five meter fast walk was the most important predictor of
6MWT distance accounting for 65% of the variance, while
exercise test duration accounted for 10%. Consistent with
the findings by Pang et al [3], VO2peak was not a signifi-
cant determinant of 6MWT distance, confirming our
hypothesis and providing further evidence that 6MWT
distance does not adequately reflect cardiorespiratory fit-
ness in the stroke population. Results from this multivar-
iate analysis must be interpreted with caution however,
due to the relatively small sample size.
Alternative functional walk tests with pre-determined test
durations, such as the Long Distance Corridor Walk test,
have been shown to achieve greater levels of cardiorespi-
ratory effort among healthy elderly [23] and might be
considered for application with individuals in the early
post-stroke phase. Arguably, exercise testing on a cycle
ergometer provides a potentially less confounded evalua-
A) Relationship between gait symmetry ratio at preferred pace 6MWT distance (r = -0.26, p = 0.13), and B) CMSA individual  scores (open symbols) and means and standard deviations (closed symbols and error bars) and 6MWT distance Figure 3
A) Relationship between gait symmetry ratio at preferred pace 6MWT distance (r = -0.26, p = 0.13), and B) CMSA individual 
scores (open symbols) and means and standard deviations (closed symbols and error bars) and 6MWT distance. There were 
no differences in 6MWT speed between participants with symmetrical versus asymmetrical gait patterns (t = 1.53, p = 0.14) 
and between those with different CMSA leg impairment scores (F = 2.17 p = 0.11).
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tion of cardiorespiratory fitness compared to walk tests, as
the effects of some stroke-related impairments are mini-
mized with the body weight supported and feet stabilized
in the pedals. Future research could compare modality-
specific differences (treadmill versus cycle ergometry) in
evaluating aerobic capacity in the early post-stroke phase.
The participants' ability to perceive effort levels due to
altered sensation in the limbs may lead to different effort
levels exerted during aerobic versus 6MWT assessments.
The current results highlight the large range of functional
compensation in spite of significant physical impairment
in the sub-acute stroke population. The wide range and
lack of association between 6MWT distance and symmetry
ratio suggests that gait symmetry is not a significant con-
tributor to functional ambulation. Further, while there
was no statistically significant difference between 6MWT
distances across CMSA scores, there was an upward trend
of longer distances with higher scores. However, there was
a wide range of distances walked by individuals at a CMSA
Stage 4 (90 to 446 m), with some participants in the range
of individuals at a CMSA Stage 7, providing additional
evidence of functional adaptation in spite of moderate
levels of leg impairment and residual spasticity. A limita-
tion of the current study is the relatively small sample size;
with a larger sample, the association between 6MWT dis-
tance and symmetry ratio and CMSA scores may be signif-
icant.
Although the 6MWT was evaluated based on the "gold
standard" maximal exercise test, there remains the unan-
swered question of the ideal method for evaluating fitness
in sub-acute stroke. Performance on maximal exercise
tests may depend on the severity of neurological impair-
ment from stroke and subsequent reduction in functional
muscle mass and oxidative capacity of the paretic muscles
[10]. Additionally, conducting a maximal exercise test is
expensive and resource-intensive and as such, these tests
may be of limited use in the typical clinical setting. Sub-
maximal measures of cardiorespiratory fitness may offer
more cost- and time-effective and clinically feasible means
of evaluation, but the validity and reliability of such tests
have yet to be established in sub-acute stroke. Further-
more, these findings do not address a key question of
whether these walking tests predict or correlate with other
factors such as strength and power, neurological status,
dynamical balance control, behavioral factors and the
amount of community activity and independence in daily
living activities. Certainly, tests based on evaluating aero-
bic demand using walking tasks need to be applied cau-
tiously and may only be suitable for a subset of stroke
patients. The findings in the current study suggest the
need for both a maximal exercise test to measure cardi-
orespiratory fitness and the 6MWT to evaluate functional
capacity in the physical assessment of individuals with
stroke.
Conclusion
The results from this study suggest that although the
6MWT may challenge the cardiorespiratory system in sub-
acute stroke survivors, it is representative of the ability for
functional ambulation and is not an adequate measure of
aerobic fitness alone. The findings demonstrate positive
correlations between gait speeds obtained from various
measures of walking function and, more importantly,
highlight differences between them. Early after stroke,
individuals tend to walk at a faster, but not maximal,
speed during functional walk tests compared to their com-
fortable pace. This suggests that gait velocity measured
over short distances is not predictive of performance on
the 6MWT. Findings from the current study have implica-
tions for the selection of assessments evaluating walking
ability and aerobic capacity in sub-acute stroke, and for
understanding the contributions of various factors, such
as neuromotor control and cardiorespiratory fitness, on
walking function.
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